These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38913573)
41. Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study. Lee EG; Lee TH; Hong Y; Ryoo J; Heo JW; Gil BM; Kang HS; Kwon SS; Kim YH PLoS One; 2021; 16(12):e0261684. PubMed ID: 34941933 [TBL] [Abstract][Full Text] [Related]
42. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis. Akiyama N; Hozumi H; Isayama T; Okada J; Sugiura K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T Respirology; 2020 Jul; 25(7):743-749. PubMed ID: 31597225 [TBL] [Abstract][Full Text] [Related]
43. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry. Snyder L; Neely ML; Hellkamp AS; O'Brien E; de Andrade J; Conoscenti CS; Leonard T; Bender S; Gulati M; Culver DA; Kaner RJ; Palmer S; Kim HJ; Respir Res; 2019 May; 20(1):105. PubMed ID: 31142314 [TBL] [Abstract][Full Text] [Related]
45. Doubkova M; Kriegova E; Littnerova S; Schneiderova P; Sterclova M; Bartos V; Plackova M; Zurkova M; Bittenglova R; Lostaková V; Siskova L; Lisa P; Suldova H; Doubek M; Psikalova J; Snizek T; Musilova P; Vasakova M Ther Adv Respir Dis; 2021; 15():17534666211042529. PubMed ID: 34515605 [TBL] [Abstract][Full Text] [Related]
46. Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis. Ley B; Swigris J; Day BM; Stauffer JL; Raimundo K; Chou W; Collard HR Am J Respir Crit Care Med; 2017 Sep; 196(6):756-761. PubMed ID: 28471697 [TBL] [Abstract][Full Text] [Related]
47. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Kinder BW; Brown KK; McCormack FX; Ix JH; Kervitsky A; Schwarz MI; King TE Chest; 2009 Jun; 135(6):1557-1563. PubMed ID: 19255294 [TBL] [Abstract][Full Text] [Related]
48. Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis. Jessen H; Hoyer N; Prior TS; Frederiksen P; Karsdal MA; Leeming DJ; Bendstrup E; Sand JMB; Shaker SB Respir Res; 2021 Jul; 22(1):205. PubMed ID: 34261485 [TBL] [Abstract][Full Text] [Related]
49. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study. Huang TH; Kuo CW; Chen CW; Tseng YL; Wu CL; Lin SH BMC Pulm Med; 2021 May; 21(1):165. PubMed ID: 33992083 [TBL] [Abstract][Full Text] [Related]